Abstract:Background: Renal denervation (RDN) has been proved to relieve cardiac hypertrophy; however, its detailed mechanisms remain obscure. This study investigated the detailed protective mechanisms of RDN against cardiac hypertrophy during hypertensive heart failure (HF). Methods: Male 5-month-old spontaneously hypertension (SHR) rats were used in a HF rat model, and male Wistar-Kyoto (WKY) rats of the same age were used as the baseline control. Myocardial hypertrophy and fibrosis were evaluated by hematoxylin-eosin (HE) staining and Masson staining. The expression of target molecule was analyzed by reverse transcription-quantitative polymerase chain reaction (RT-qPCR), Western blot, immunohistochemical and immunofluorescence, respectively. Cardiomyocyte hypertrophy was induced by norepinephrine (NE) in H9c2 cells in vitro and evaluated by brain natriuretic peptide (BNP), atrial natriuretic peptide (ANP), β-myosin heavy chain (β-MHC), and α-myosin heavy chain (α-MHC) levels. Oxidative stress was determined by malondialdehyde (MDA) level, superoxide dismutase (SOD), and glutathione peroxidase (GSH-Px) enzyme activities. Mitochondrial function was measured by mitochondrial membrane potential, adenosine triphosphate (ATP) production, mitochondrial DNA (mtDNA) number, and mitochondrial complex I-IV activities. Molecular mechanism was assessed by dual luciferase reporter and chromatin immunoprecipitation (ChIP) assays. Results: RDN decreased sympathetic nerve activity, attenuated myocardial hypertrophy and fibrosis, and improved cardiac function in the rat model of HF. In addition, RDN ameliorated mitochondrial oxidative stress in myocardial tissues as evidenced by reducing MDA and mitochondrial reactive oxygen species (ROS) levels, and enhancing SOD and GSH-Px activities. Moreover, phosphofurin acid cluster sorting protein 2 (PACS-2) and broad-complex, tramtrak and bric à brac (BTB) domain and cap'n'collar (CNC) homolog 1 (BACH1) were down-regulated by RDN. In NE-stimulated H9c2 cells, PACS-2 and BACH1 levels were markedly elevated, and knockdown of them could suppress NE-induced oxidative stress, cardiomyocyte hypertrophy, fibrosis, as well as mitochondrial dysfunction. Transforming growth factor beta1(TGFβ1)/SMADs signaling pathway was inactivated by RDN in the HF rats, which sequentially inhibited specificity protein 1 (SP1)-mediated transcription of PACS2 and BACH1. Conclusion: Collectively, these data demonstrated that RDN improved cardiac hypertrophy and sympathetic nerve activity of HF rats via repressing BACH1 and PACS-2-mediated mitochondrial oxidative stress by inactivating TGF-β1/SMADs/SP1 pathway, which shed lights on the cardioprotective mechanism of RDN in HF.

Rapamycin Attenuated Cardiac Hypertrophy Induced by Isoproterenol and Maintained Energy Homeostasis Via Inhibiting NF-κB Activation

Rapamycin Inhibits Cardiac Hypertrophy by Promoting Autophagy via the MEK/ERK/Beclin-1 Pathway.

The mammalian target of rapamycin modulates the immunoproteasome system in the heart

Renal Denervation Findings on Cardiac and Renal Fibrosis in Rats with Isoproterenol Induced Cardiomyopathy

Mammalian target of rapamycin inhibition attenuates myocardial ischaemia-reperfusion injury in hypertrophic heart

Rapamycin Improves Cardiac Function of Myocardial Infarction Mice by Reducing the Expression of Inflammatory Cytokines

Rapamycin Protects Cardiomyocytes Against Anoxia/Reoxygenation Injury by Inducing Autophagy Through the PI3k/Akt Pathway

Single-Dose Treatment with Rapamycin Preserves Post-Ischemic Cardiac Function through Attenuation of Fibrosis and Inflammation in Diabetic Rabbit

Hypertrophied Myocardium is Vulnerable to Ischemia/reperfusion Injury and Refractory to Rapamycin-Induced Protection Due to Increased Oxidative/nitrative Stress.

Rapamycin Attenuates Mouse Liver Ischemia and Reperfusion Injury by Inhibiting Endoplasmic Reticulum Stress

Renal denervation improves mitochondrial oxidative stress and cardiac hypertrophy through inactivating SP1/BACH1-PACS2 signaling

Regulatory effect of rapamycin on recruitment and function of myeloid-derived suppressor cells in heart failure

Rapamycin restores brain vasculature, metabolism, and blood-brain barrier in an inflammaging model

Rapamycin Attenuates Atrial Fibrosis in 5/6 Nephrectomized Rats by Inhibiting Mammalian Target of Rapamycin and Profibrotic Signaling

Modulating autophagy improves cardiac function in a rat model of early-stage dilated cardiomyopathy.

Effect of Rapamycin on Hepatic Metabolomics of Non-Alcoholic Fatty Liver Rats Based on Non-Targeted Platform

Renal Sympathetic Denervation Alleviates Myocardial Fibrosis Following Isoproterenol-Induced Heart Failure

Rapamycin Improves Palmitate-Induced ER Stress/nf Κ B Pathways Associated with Stimulating Autophagy in Adipocytes.

Effect of rapamycin on the expression of inflammatory cytokines TNF-α and IL-1β in LPS-stimulated RAW 264.7 cells

Rapamycin Represses Myotube Hypertrophy and Preserves Viability of C2C12 Cells During Myogenesis in Vitro.

Renal Sympathetic Denervation Improves Myocardial Apoptosis in Rats with Isoproterenol-Induced Heart Failure by Downregulation of Tumor Necrosis Factor-Α and Nuclear Factor-Κb.